Findings

What do systematic reviews say?

6 questions · 6 findings · 1 reviews · Skin

No studies found 1 · 16.7%GRADE not reported 0 · 0%Very low 0 · 0%Low 2 · 33.3%Moderate 3 · 50%High 0 · 0%

Recurrence of cellulitis · People with recurrent erysipelas or cellulitis

Antibiotic prophylaxis probably leads to lower recurrence of cellulitis compared with no treatment/placebo (moderate certainty).

1 finding from 1 review

Interventions for the prevention of recurrent erysipelas and cellulitis 2017 · Cochrane Headline outcomes only
RR 0.31 [0.13, 0.72]
5 studies · 513 participants
Moderate

Incidence rate of cellulitis · People with recurrent erysipelas or cellulitis

Antibiotic prophylaxis probably leads to lower incidence rate of cellulitis compared with no treatment/placebo (moderate certainty).

1 finding from 1 review

Interventions for the prevention of recurrent erysipelas and cellulitis 2017 · Cochrane Headline outcomes only
RR 0.44 [0.22, 0.89]
4 studies · 473 participants
Moderate

Time to next episode of cellulitis · People with recurrent erysipelas or cellulitis

Antibiotic prophylaxis probably leads to lower time to next episode of cellulitis compared with no treatment/placebo (moderate certainty).

1 finding from 1 review

Interventions for the prevention of recurrent erysipelas and cellulitis 2017 · Cochrane Headline outcomes only
HR 0.51 [0.34, 0.78]
3 studies · 437 participants
Moderate

Hospital admissions · People with recurrent erysipelas or cellulitis

Antibiotic prophylaxis showed no clear difference in hospitalisation compared with no treatment/placebo (low certainty).

1 finding from 1 review

Interventions for the prevention of recurrent erysipelas and cellulitis 2017 · Cochrane Headline outcomes only
RR 0.77 [0.37, 1.57]
3 studies · 429 participants
Low

Adverse reactions to treatment Proportion of participants with adverse reactions to treatment · People with recurrent erysipelas or cellulitis

Antibiotic prophylaxis showed no clear difference in any adverse reactions compared with no treatment/placebo (low certainty).

1 finding from 1 review

Interventions for the prevention of recurrent erysipelas and cellulitis 2017 · Cochrane Headline outcomes only
RR 0.87 [0.58, 1.3]
4 studies · 469 participants
Low

Quality of life · People with recurrent erysipelas or cellulitis

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for the prevention of recurrent erysipelas and cellulitis 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found